Madrid, Spain

Joaquín Martínez López

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joaquín Martínez López: Innovator in Medical Diagnostics

Introduction

Joaquín Martínez López is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of medical diagnostics, particularly in the detection and quantification of minimal residual disease (MRD) in patients who have undergone treatment for proliferative diseases. With a total of 2 patents, his work is paving the way for advancements in patient care and disease management.

Latest Patents

Martínez López's latest patents include a method for determining the presence or absence of minimal residual disease in a subject who has been treated for a disease. This invention focuses on a comprehensive method, kit, and system designed to assess MRD effectively. Additionally, he has developed a method for quantifying the level of minimal residual disease in treated subjects, which is crucial for monitoring treatment efficacy and guiding further therapeutic decisions.

Career Highlights

Throughout his career, Joaquín Martínez López has worked with esteemed organizations such as Fundación de Investigación Hospital 12 de Octubre and Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre. His experience in these institutions has allowed him to collaborate on groundbreaking research and contribute to the advancement of medical science.

Collaborations

Martínez López has collaborated with notable colleagues, including Santiago Barrio García and Rosa María Ayala Díaz. These partnerships have fostered a collaborative environment that enhances innovation and research in the medical field.

Conclusion

Joaquín Martínez López is a distinguished inventor whose work in medical diagnostics is making a significant impact on patient care. His innovative methods for detecting and quantifying minimal residual disease are essential for improving treatment outcomes. His contributions to the field will undoubtedly continue to influence future advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…